I am stage 1 er/pr - , her2+ and have been on weekly herceptin since February. I also read about the Finnish trial that included 9 weeks of Hercepin. My onc. said that was not conclusive enough since it was based on a small group (a few hundred) of women. The 1 year and 2 year trials include thousands of women.
But I still felt relieved after I passed my 3-month treatment, because I figured at least I had done as much as the Finnish study.
I'm also torn between wanting to switch to every 3 weeks and staying at 1 week. Have there been studies to show which is safer? I am worried about my heart. My echo results at 3 months were LEF dropped from 65 to 60. My Onc. said there is a margin of error, though my previous 2 echos had both been 65.
Anyone who switched from 1 week to 3 weeks or 3 weeks to 1 week notice any differences?
- Anna
|